Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Payables (2019 - 2025)

Pulmonx (LUNG) has disclosed Payables for 7 consecutive years, with $6.5 million as the latest value for Q3 2025.

  • Quarterly Payables rose 39.57% to $6.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.5 million through Sep 2025, up 39.57% year-over-year, with the annual reading at $7.0 million for FY2024, 91.76% up from the prior year.
  • Payables for Q3 2025 was $6.5 million at Pulmonx, down from $6.7 million in the prior quarter.
  • The five-year high for Payables was $18.9 million in Q4 2021, with the low at $1.8 million in Q4 2022.
  • Average Payables over 5 years is $8.0 million, with a median of $6.5 million recorded in 2025.
  • The sharpest move saw Payables tumbled 90.23% in 2022, then surged 180.31% in 2024.
  • Over 5 years, Payables stood at $18.9 million in 2021, then crashed by 90.23% to $1.8 million in 2022, then skyrocketed by 97.62% to $3.7 million in 2023, then surged by 91.76% to $7.0 million in 2024, then dropped by 6.83% to $6.5 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $6.5 million, $6.7 million, and $12.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.